Evaluation of Biofilm Formation and Antibiotic Resistance Pattern in Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains

被引:10
作者
Jomehzadeh, Nabi [1 ]
Ahmadi, Khadijeh [1 ]
Nasiri, Zahra [1 ]
机构
[1] Abadan Univ Med Sci, Sch Med, Dept Microbiol, Abadan, Iran
来源
BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL | 2022年 / 6卷 / 02期
关键词
Biofilm; escherichia coli; extended-spectrum beta-lactamase; urinary tract infection; NONTUBERCULOUS MYCOBACTERIA; MOLECULAR CHARACTERIZATION; RISK-FACTORS;
D O I
10.4103/bbrj.bbrj_270_21
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The increasing prevalence of multidrug-resistant (MDR) Escherichia coli strains, especially extended-spectrum beta-lactamase (ESBL)-producing strains, has become a global health concern. This study was aimed to determine the frequency of bla(CTX-M), bla(TEM), and bla(SHV) genes among E. coli isolates from urinary tract infection (UTI) and evaluate their antibiotic resistance pattern. Methods: Totally 98 E. coli isolates were recovered from urine samples of UTI-diagnosed patients. Antibiotic resistance and ESBL production were evaluated by disk diffusion and combined disk methods according to the Clinical Laboratory Standards Institute guidelines. The biofilm formation ability of isolates was assessed using the tube adherence method. ESBL-positive isolates were screened for bla(TEM), bla(CTX-M), and bla(SHV) genes by polymerase chain reaction. Results: Among the examined isolates, 25 (25.5%) were detected as ESBL producers and harbored at least one of the studied genes. The bla(CTX-M) was the predominant (44%) gene, followed by bla(TEM) (24%) and bla(SHV) (8%). The isolates revealed variable resistance levels to all antimicrobials, out of which 55.1% were conferred a high resistance rate to different antibiotic classes and considered MDR. Phenotypically, 42.85% of the isolates were biofilm formers, of which the majority (38%) formed moderate biofilms. Conclusions: This study showed that the ESBL-positive isolates were more resistant to some first-line antibiotics, and this highlights the necessity to control and monitor the prescribed antibiotics used for empirical treatment for UTI patients.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 50 条
  • [41] Prevalence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh
    Rahman, MM
    Haq, JA
    Hossain, MA
    Sultana, R
    Islam, F
    Islam, AHMS
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (05) : 508 - 510
  • [42] Prevalence of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Food-Producing Animals
    Hiroi, Midori
    Yamazaki, Fumie
    Harada, Tetsuya
    Takahashi, Naomi
    Iida, Natsuko
    Noda, Yoshihiro
    Yagi, Miya
    Nishio, Tomohiro
    Kanda, Takashi
    Kawamori, Fumihiko
    Sugiyama, Kanji
    Masuda, Takashi
    Hara-Kudo, Yukiko
    Ohashi, Norio
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 2012, 74 (02) : 189 - 195
  • [43] Characteristics of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Retail Meats and Shrimp at a Local Market in Vietnam
    Quoc Phong Le
    Ueda, Shuhei
    Thi Ngoc Hue Nguyen
    Thi Van Khanh Dao
    Thi Ai Van Hoang
    Thi Thuy Nga Tran
    Hirai, Itaru
    Nakayama, Tatsuya
    Kawahara, Ryuji
    Thai Hung Do
    Quang Mai Vien
    Yamamoto, Yoshimasa
    [J]. FOODBORNE PATHOGENS AND DISEASE, 2015, 12 (08) : 719 - 725
  • [44] Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli
    Rodriguez-Bano, J.
    Navarro, M. D.
    Romero, L.
    Muniain, M. A.
    de Cueto, M.
    Galvez, J.
    Perea, E. J.
    Pascual, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (02) : 180 - 183
  • [45] Cefmetazole for extended-spectrum β-lactamase-producing Enterobacteriaceae in pediatric pyelonephritis
    Araki, Kotaro
    Fukuoka, Kahoru
    Higuchi, Hiroshi
    Aizawa, Yuta
    Horikoshi, Yuho
    [J]. PEDIATRICS INTERNATIONAL, 2019, 61 (06) : 572 - 577
  • [46] Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs
    Maslikowska, J. A.
    Walker, S. A. N.
    Elligsen, M.
    Mittmann, N.
    Palmay, L.
    Daneman, N.
    Simor, A.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2016, 92 (01) : 33 - 41
  • [47] Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli
    Metan, G
    Zarakolu, P
    Çakir, B
    Hascelik, G
    Uzun, O
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (03) : 254 - 257
  • [48] Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections
    Bayraktar, Banu
    Pelit, Suleyman
    Bulut, Mehmet Emin
    Aktas, Elif
    [J]. MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2019, 53 (01): : 70 - 75
  • [49] Determination of Antibiotic Resistance and Pulsed-Field Gel Electrophoresis Profiles for the Extended-Spectrum β-Lactamase Producing Escherichia coli
    Ozer, Turkan Toka
    Karagoz, Alper
    Yalcin, Gozde
    Andac, Cenk A.
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2018, 11 (03)
  • [50] Prevalence and antibiotic resistance pattern of extended spectrum beta lactamase producing Escherichia coli isolated from urinary tract infection
    Rajabnia, Mohsen
    Forghani, Mohammad Saad
    Hasani, Sabah
    Bahadoram, Mohammad
    Mohammadi, Mahsa
    Barahman, Maedeh
    [J]. JOURNAL OF RENAL INJURY PREVENTION, 2019, 8 (02): : 78 - 81